Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ONCS > SEC Filings for ONCS > Form 8-K on 8-Aug-2013All Recent SEC Filings

Show all filings for ONCOSEC MEDICAL INC



Change in Directors or Principal Officers, Financial Statements and Exhibits

Item 5.02 Departure of Directors or Certain Officers;
Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


On August 2, 2013, the Compensation Committee (the "Committee") of the Board of Directors of OncoSec Medical Incorporated ("OncoSec") approved an amendment (the "Amendment") to that certain employment agreement, dated as of May 18, 2011, by and between OncoSec and Veronica Vallejo, OncoSec's Chief Financial Officer, (the "Employment Agreement"). Pursuant to the Amendment, (i) the severance payment payable to Ms. Vallejo in the event of her termination is to equal twelve (12) months (the "Severance Period") of her annual salary at the time of termination and (ii) the period for which the Company will pay for applicable premium costs for continued group health plan coverage was increased to the Severance Period, subject in each case to the terms of the Employment Agreement. Prior to the Amendment, the Employment Agreement provided for a Severance Period of six (6) months. A copy of the Amendment is attached as Exhibit 10.1 to this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.                                Description
10.1          Amendment No. 1 to Employment Agreement, by and between OncoSec
              Medical Incorporated and Veronica Vallejo, dated as of August 2, 2013

  Add ONCS to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ONCS - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.